A grading scale for epistaxis in hereditary haemorrhagic teleangectasia

Rhinology

Volumn 46, Issue 4, 2008, Pages 281-284

  Al Deen, Sinan ^a   Bachmann Harildstad, G ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Epistaxis; Epistaxis classification; Epistaxis grading; Hereditary haemorrhagic teleangectasia; Olser disease

Indexed keywords

ARTICLE; CLASSIFICATION; EPISTAXIS; HOSPITALIZATION; HUMAN; PATHOPHYSIOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; RENDU OSLER WEBER DISEASE;

EPISTAXIS; HUMANS; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TELANGIECTASIA, HEREDITARY HEMORRHAGIC;

EID: 57749110396     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Lund, V. J. and Howard, D. J. A treatment algorithm for the management of epistaxis in hereditary hemorrhagic telangiectasia. Am J Rhinol 1999; 13: 319-322.
2. Shah, R. K., Dhingra, J. K., and Shapshay, S. M. Hereditary hemorrhagic telangiectasia: a review of 76 cases. Laryngoscope 2002; 112: 767-773.
3. Sadick, H., Fleischer, I., Goesster, U., Hormann, K., and Sadick, M. Twenty-four-hour and annual variation in onset of epistaxis in Osler disease. Chronobiol Int 2007; 24: 357-364.
4. Bergler, W., Sadick, H., Gotte, K., Riedel, F., and Hormann, K. Topical estrogens combined with argon plasma coagulation in the management of epistaxis in hereditary hemorrhagic telangiectasia. Ann Otol Rhinol Laryngol 2002; 111: 222-228.
5. Lennox, P. A., Harries, M., Lund, V. J., and Howard, D. J. A retrospective study of the role of the argon laser in the management of epistaxis secondary to hereditary haemorrhagic telangiectasia. J Laryngol Otol 1997; 111: 34-37.
6. Hitchings, A. E., Lennox, P. A., Lund, V. J., and Howard, D. J. The effect of treatment for epistaxis secondary to hereditary hemorrhagic telangiectasia. Am J Rhinol 2005; 19: 75-78.
7. Lennox, P. A., Hitchings, A. E., Lund, V. J., and Howard, D. J. The SF-36 health status questionnaire in assessing patients with epistaxis secondary to hereditary hemorrhagic telangiectasia. Am J Rhinol 2005; 19: 71-74.
8. Rebeiz, E. E., Bryan, D. J., Ehrlichman, R. J., and Shapshay, S. M. Surgical management of life-threatening epistaxis in Osler-Weber-Rendu disease. Ann Plast Surg 1995; 35: 208-213.
9. Pagella, F., Semino, L., Olivieri, C., Corno, S., Dore, R., Draghi, F., Lanzarini, L., Vespro, V., Buscarini, E., and Danesino, C. Treatment of epistaxis in hereditary hemorrhagic telangiectasia patients by argon plasma coagulation with local anesthesia. Am J Rhinol 2006; 20: 421-425.
10. Geisthoff, U. W., Heckmann, K., D'Amelio, R., Grunewald, S., Knobber, D., Falkai, P., and Konig, J. Health-related quality of life in hereditary hemorrhagic telangiectasia. Otolaryngol Head Neck Surg 2007; 136: 726-733.
11. Pasculli, G., Resta, F., Guastamacchia, E., Di, Gennaro L., Suppressa, P., and Sabha, C. Health-related quality of life in a rare disease: hereditary hemorrhagic telangiectasia (HHT) or Rendu-Osler-Weber disease. Qual Life Res 2004; 13: 1715-1723.
12. Ware, J. E., Jr. SF-36 health survey update. Spine 15-12-2000; 25: 3130-3139.